Advancements in Nanocarrier Systems for Nose-to-Brain Drug Delivery
Top Cited Papers
Open Access
- 23 April 2025
- journal article
- review article
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (5) , 615
Abstract
In recent decades, nose-to-brain drug delivery has shown effectiveness in treating many central nervous system diseases. Intranasally administered drugs can be delivered to the brain through the olfactory and trigeminal pathways that bypass the blood–brain barrier. However, nose-to-brain drug delivery is challenging due to the inadequate nasal mucosa absorption of drugs and the short retention time of the intranasal formulations. These problems can be minimized through the use of nano-drug delivery systems, such as micelles, polymeric nanoparticles, nanoemulsions, liposomes, solid lipid nanoparticles, and nanostructured lipid carriers. They can enhance the drug’s bioavailability in the brain via increases in drug solubility, permeation, and stability. Nose-to-brain nano-drug delivery systems have been evaluated in vivo by a number of research groups. This review aims to provide an overview of nose-to-brain delivery and recent advances in the development of nano-drug delivery systems for delivering drugs from the nose to the brain to improve the treatment of some central nervous system diseases.Keywords
This publication has 158 references indexed in Scilit:
- Insights into the formulation of lipid nanoparticles for the optimization of mRNA therapeuticsWIREs Nanomedicine and Nanobiotechnology, 2024
- A Review on Nanosystem-Based Delivery of Tofacitinib for Enhanced Treatment of Autoimmune Diseases and InflammationBioNanoScience, 2024
- Nose‐to‐brain delivery of nanotherapeutics: Transport mechanisms and applicationsWIREs Nanomedicine and Nanobiotechnology, 2024
- In Vitro Comparison of Local Nasal Vaccine Delivery and Correlation with Device Spray PerformancePharmaceutical Research, 2022
- RETRACTED ARTICLE: Niosomes: a novel targeted drug delivery system for cancerMedical Oncology, 2022
- Preparation of Ondansetron Hydrochloride-Loaded Nanostructured Lipid Carriers Using Solvent Injection Method for Enhancement of Pharmacokinetic PropertiesPharmaceutical Research, 2019
- A novel device for delivery of intranasal particulate medication: a pilot studyInternational Forum of Allergy & Rhinology, 2013
- Nasal drug delivery devices: characteristics and performance in a clinical perspective—a reviewDrug Delivery and Translational Research, 2012
- Intranasal delivery to the central nervous system: Mechanisms and experimental considerationsJournal of Pharmaceutical Sciences, 2010
- Effects of Dose, pH, and Osmolarity on Nasal Absorption of Secretin in Rats II: Histological Aspects of the Nasal Mucosa in Relation to the Absorption Variation Due to the Effects of pH and OsmolarityJournal of Pharmaceutical Sciences, 1987